New drug combo aims to tackle lymphoma without chemo
Disease control
Ongoing
This phase 2 trial is testing a combination of two immunotherapy drugs, glofitamab and obinutuzumab, as the first treatment for people with follicular lymphoma or marginal zone lymphoma. The study includes 47 participants who have not had prior therapy for their lymphoma. The goa…
Phase: PHASE2 • Sponsor: Reid Merryman, MD • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC